Int. J. Mol. Sci. 2012, 13(4), 4367-4387; doi:10.3390/ijms13044367
Article

Evaluation of the Adenocarcinoma-Associated Gene AGR2 and the Intestinal Stem Cell Marker LGR5 as Biomarkers in Colorectal Cancer

1,2,* email, 2email, 1email, 3email, 3email, 2email, 4,5email, 2email, 2email, 6email, 2email and 1,5email
Received: 1 March 2012; in revised form: 20 March 2012 / Accepted: 23 March 2012 / Published: 5 April 2012
(This article belongs to the Special Issue Advances in Molecular Oncology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: We aim to estimate the diagnostic performances of anterior gradient homolog-2 (AGR2) and Leucine-rich repeat-containing-G-protein-coupled receptor 5 (LGR5) in peripheral blood (PB) as mRNA biomarkers in colorectal cancer (CRC) and to explore their prognostic significance. Real-time PCR was used to analyze AGR2 and LGR5 in 54 stages I-IV CRC patients and 19 controls. Both mRNAs were significantly increased in PB from CRC patients compared to controls. The area under the receiver-operating characteristic curves were 0.722 (p = 0.006), 0.376 (p = 0.123) and 0.767 (p = 0.001) for AGR2, LGR5 and combined AGR2/LGR5, respectively. The AGR2/LGR5 assay resulted in 67.4% sensitivity and 94.7% specificity. AGR2 correlated with pT3–pT4 and high-grade tumors. LGR5 correlated with metastasis, R2 resections and high-grade. The progression-free survival (PFS) of patients with high AGR2 was reduced (p = 0.037; HR, 2.32), also in the stage I-III subgroup (p = 0.046). LGR5 indicated a poor prognosis regarding both PFS (p = 0.007; HR, 1.013) and overall survival (p = 0.045; HR, 1.01). High AGR2/LGR5 was associated with poor PFS (p = 0.014; HR, 2.8) by multivariate analysis. Our findings indicate that the assessment of AGR2 and LGR5 in PB might reflect the presence of circulating tumor cells (CTC) and stem cell like CTC in CRC. Increased AGR2 and LGR5 are associated with poor outcomes.
Keywords: colorectal cancer; real-time PCR; circulating tumor cells; prognostic markers; stem cells; anterior gradient homolog-2; leucine-rich repeat-containing G-protein-coupled receptor 5
PDF Full-text Download PDF Full-Text [358 KB, Updated Version, uploaded 19 June 2014 04:14 CEST]
The original version is still available [324 KB, uploaded 19 June 2014 04:14 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Valladares-Ayerbes, M.; Blanco-Calvo, M.; Reboredo, M.; Lorenzo-Patiño, M.J.; Iglesias-Díaz, P.; Haz, M.; Díaz-Prado, S.; Medina, V.; Santamarina, I.; Pértega, S.; Figueroa, A.; Antón-Aparicio, L.M. Evaluation of the Adenocarcinoma-Associated Gene AGR2 and the Intestinal Stem Cell Marker LGR5 as Biomarkers in Colorectal Cancer. Int. J. Mol. Sci. 2012, 13, 4367-4387.

AMA Style

Valladares-Ayerbes M, Blanco-Calvo M, Reboredo M, Lorenzo-Patiño MJ, Iglesias-Díaz P, Haz M, Díaz-Prado S, Medina V, Santamarina I, Pértega S, Figueroa A, Antón-Aparicio LM. Evaluation of the Adenocarcinoma-Associated Gene AGR2 and the Intestinal Stem Cell Marker LGR5 as Biomarkers in Colorectal Cancer. International Journal of Molecular Sciences. 2012; 13(4):4367-4387.

Chicago/Turabian Style

Valladares-Ayerbes, Manuel; Blanco-Calvo, Moisés; Reboredo, Margarita; Lorenzo-Patiño, María J.; Iglesias-Díaz, Pilar; Haz, Mar; Díaz-Prado, Silvia; Medina, Vanessa; Santamarina, Isabel; Pértega, Sonia; Figueroa, Angélica; Antón-Aparicio, Luis M. 2012. "Evaluation of the Adenocarcinoma-Associated Gene AGR2 and the Intestinal Stem Cell Marker LGR5 as Biomarkers in Colorectal Cancer." Int. J. Mol. Sci. 13, no. 4: 4367-4387.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert